Adipose tissue-derived adipokines (i.e., leptin/adiponectin/resistin) play important roles in the regulation of several pathophysiologic processes through the activation of specific receptors. However, although adipokines and their receptors are widely distributed in many tissues and exhibit a clear modulation according to particular metabolic conditions (e.g., obesity and/or fasting), their expression, regulation, and putative action on normal prostate glands (PGs; a hormonedependent organ tightly regulated by the endocrine-metabolic milieu) are still to be defined. Different in vivo/in vitro models were used to comprehensively characterize the expression pattern and actions of different adipokine systems (i.e., leptin/adiponectin/resistin/receptors) in mouse PGs. Adiponectin, resistin, and adiponectin receptors (1 and 2) and leptin receptor are coexpressed at different levels in PG cells, wherein they are finely regulated under fasting and/or obesity conditions. Furthermore, treatment with different adipokines exerted both homologous and heterologous regulation of specific adipokines/receptor-synthesis and altered the expression of key proliferation and oncogenesis markers (i.e., Ki67/c-Myc/p53) in mouse PG cell cultures, wherein some of these actions might be elicited through extracellular signal-regulated kinase (ERK) activation. Moreover, treatment with leptin, adiponectin, and resistin differentially regulated key functional parameters [i.e., proliferation and migration capacity and/or prostate-specific antigen (PSA) secretion] in human normal and/or tumoral prostate cell lines. Altogether, our data show that various adipokine and receptor systems are differentially expressed in normal PG cells; that their expression is under a complex ligand-and receptor-selective regulation under extreme metabolic conditions; and that they mediate distinctive and common direct actions in normal and tumoral PG cells (i.e., homologous and heterologous regulation of ligand and receptor synthesis, ERK signaling activation, modulation of proliferation markers, proliferation and migration capacity, and PSA secretion), suggesting a relevant role of these systems in the regulation of PG pathophysiology. (Endocrinology 158: 3540-3552, 2017) A dipose tissue produces and releases a variety of factors that regulate many physiologic functions, including the adipokines leptin, adiponectin, and resistin, which play relevant roles in the modulation of energy balance; glucose homeostasis; insulin sensitivity/resistance; immune, inflammatory, or vascular systems; lipid and bone metabolism; and steroid synthesis metabolism (1-9). To exert these actions, these adipokines act through specific receptors [i.e., leptin receptor (Lepr) and adiponectin receptors 1 and 2 (Adipor1 and Adipor2), the Abbreviations: Adipor1, adiponectin receptor 1; Adipor2, adiponectin receptor 2; AKT, protein kinase b serine/threonine kinase 1; ATCC, American Type Culture Collection; cDNA, complementary DNA; ERK, extracellular signal-regulated kinase; FBS, fetal bovine serum; HF, high-fat; Lepr, leptin receptor; LF, low-fat; mRNA, messenger RNA; PBS, phosphatebuffered saline; PCa, prostate cancer; PG, prostate gland; PPCC, primary prostate cell culture; PSA, prostate-specific antigen; qPCR, quantitative polymerase chain reaction; TBS-T, Tris-buffered saline containing 0.1% Tween-20. resistin receptor having not yet been unequivocally identified (10)], which are widely expressed in many tissues and organs (e.g., hypothalamus, muscle, pancreas, and liver) (11, 12) . This confirms that these adipokines represent relevant regulatory circuits to modulate numerous functions in multiple cell types. Interestingly, adipose and other tissues coexpress certain adipokines and their receptors (11) (12) (13) (14) , suggesting the existence of autoregulatory loops in these tissues. Adipokines are finely regulated under different metabolic conditions, such as obesity and fasting, which could affect the normal physiology of different tissues and organs. In particular, leptin and resistin exhibit similar behavior: They are elevated under obesity and reduced under fasting conditions (15) (16) (17) . This could contribute to the impaired metabolic status observed in obesity inasmuch as leptin is associated with immune system activation (18) and resistin with an inflammatory state, immunomodulation (8, 9), and insulin resistance (19, 20) . On the other hand, adiponectin shows the opposite pattern of regulation: Its levels are reduced in obesity (21), which could favor the high glucose and insulin levels observed in this state, as adiponectin has been associated with an improved glucose uptake and insulin sensitivity (6, 7, 22) . In addition, the low levels of adiponectin observed in obesity may also contribute to an increased inflammatory state in this metabolic status because this hormone is considered an anti-inflammatory factor (23).
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Adipokines are finely regulated under different metabolic conditions, such as obesity and fasting, which could affect the normal physiology of different tissues and organs. In particular, leptin and resistin exhibit similar behavior: They are elevated under obesity and reduced under fasting conditions (15) (16) (17) . This could contribute to the impaired metabolic status observed in obesity inasmuch as leptin is associated with immune system activation (18) and resistin with an inflammatory state, immunomodulation (8, 9) , and insulin resistance (19, 20) . On the other hand, adiponectin shows the opposite pattern of regulation: Its levels are reduced in obesity (21) , which could favor the high glucose and insulin levels observed in this state, as adiponectin has been associated with an improved glucose uptake and insulin sensitivity (6, 7, 22) . In addition, the low levels of adiponectin observed in obesity may also contribute to an increased inflammatory state in this metabolic status because this hormone is considered an anti-inflammatory factor (23) .
In this scenario, the role of adipokines on the physiologic regulation of the prostate gland (PG), an organ closely regulated by the endocrine milieu, is still poorly known. To the best of our knowledge, although adipokine receptors (Lepr, Adipor1, and Adipor2) have been found in normal PGs (13, 14) , the information available about the expression, modulation, and effects of adiponectin, leptin, and resistin on prostate function is controversial and mainly related to cancer progression (24) (25) (26) . For this reason, in the current study we primarily aimed to characterize the expression levels as well as the direct actions of these adipokine-receptor systems in normal murine PGs (i.e., homologous and heterologous regulation, activation of extracellular signal-regulated kinase (ERK) and protein kinase b serine/threonine kinase 1 (AKT) signaling pathways, and modulation of different proliferation markers), as well as their regulation under different metabolic conditions (obesity and fasting). We also determined, in parallel, the direct actions of adiponectin, leptin, and resistin on different pathophysiologic parameters [i.e., proliferation rate, migration capacity, and/or secretion of prostate-specific antigen (PSA)] on different human prostate cell lines [normal-like (i.e., RWPE-1) and tumoral (androgen-dependent LNCaP and androgen-independent PC3 cells)].
Materials and Methods

Animal models
All experimental procedures were carried out in accordance with applicable guidelines and regulations, following the European Regulations for Animal Care and under the approval of the University of Cordoba and the Regional Government Research Ethics Committees. C57BL/6J male mice were obtained at weaning from Janvier Laboratories (Le Genest-Saint-Isle, France) and used to (1) characterize the expression profile of different adipokine and receptor (i.e., leptin, adiponectin, and resistin) systems in PGs (n = 6 mice, 12 weeks old; experiment 1); (2) explore the modulation of the expression of these adipokines and their receptors in response to fasting (12 and 24 hours) compared with fed littermate controls (n = 5 to 6 mice, 13 to 18 weeks old¸experiment 2); (3) explore the modulation of the expression of these adipokines and their receptors in a model of diet-induced obesity (obese vs lean control mice; n = 5 mice, 27 weeks old, experiment 3); and (4) study the direct effect of leptin, adiponectin, and resistin on the expression of different key genes in normal mouse PGs [by using primary prostate cell cultures (PPCCs); n = 6 to 8 mice, 12 weeks old, experiment 4]. Mice were fed with a standard rodent diet (8.4% kcal fat, 72.4% kcal carbohydrates, 19.3% kcal proteins; reference: A04, SAFE Diets, Barcelona, Spain), except those of experiment 3, which were fed a low-fat (LF) or a high-fat (HF) diet. All mice were housed in sterile filter-capped cages maintained under standard conditions of light (12-hour light/dark cycle; lights on at 0700) and temperature (22°C to 24°C), with free access to sterilized diet and water.
In the fasting study (experiment 2), mice were fasted for 12 hours or 24 hours before euthanasia [n = 5 to 6 mice per group (control, fasted for 12 hours and 24 hours)]. To generate the diet-induced obese model, n = 5 mice per group were housed individually and fed (starting at 4 weeks until 23 weeks of age), an LF or HF diet (Research Diets Inc., New Brunswick, NJ). The LF diet consisted of 10% kcal fat, 70% kcal carbohydrates, and 20% kcal proteins; the HF diet consisted of 60% kcal fat, 20% kcal carbohydrates, and 20% kcal proteins; LF and HF were micronutrient-matched diets. Mice were handled daily to acclimatize them to the experimental procedures and personnel for 1 to 2 weeks before euthanasia. Mice were euthanized by decapitation without anesthesia (between 0800 and 1000 hours). PGs were immediately excised, weighed, and snap-frozen in liquid nitrogen and then stored at 280°C until the specific analyses (experiments 1 to 3). Additionally, some PGs were excised and maintained in appropriate media (see next section for details) for further dispersion and cell culture (experiment 4).
Normal PPCCs from mice
Whole PGs (two pooled prostates from normal-control mice per experiment; n = 3 to 4 independent experiments) were dispersed into single cells as previously reported (27) . All the individual prostate cultures showed cell viability .95%, as determined by the trypan blue dye exclusion method [American Type Culture Collection (ATCC), Manassas, VA].
To avoid fibroblast contamination, suspensions of dispersed prostate cells were filtered through a nylon gauze with a 130-mM mesh, and cells were plated (150,000 cells per well) and cultured (at 37°C and 5% CO 2 ) in appropriate Dulbecco's modified Eagle medium [supplemented with 10% fetal bovine serum (FBS), 1% antibiotic-antimycotic, and 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO)], in which L-valine was replaced for D-Valine to selectively inhibit fibroblast proliferation and overgrowth (SeraLab, Haywards Heath, United Kingdom). After 24 to 36 hours in culture, PPCCs were preincubated in serum-free medium for 2 hours; subsequently, the medium was replaced with serum-free medium containing medium alone (control) or mouse leptin (10 ng/mL), adiponectin (10 nM), or resistin (10 nM) (Sigma-Aldrich). At visual inspection of primary cell cultures at the time of experimental assays, cells did not display the typical fibroblastlike morphology. Doses for leptin, adiponectin, and resistin were selected on the basis of previous studies (28) (29) (30) (31) , which are on the range of physiologic concentrations of these hormones in the circulation. Cell cultures were incubated with the different treatments (three to four wells per treatment, three to five independent experiments), and then total RNA or protein was extracted [24 hours and/or 8 minutes of incubation, as described later and as previously reported (27) (28) (29) (30) ].
RNA extraction, reverse transcription, and quantitative real-time polymerase chain reaction Total RNA from whole PGs was isolated by using the AllPrep DNA/RNA/Protein Mini Kit following the manufacturer's instructions and treated with DNase (Qiagen, Limburg, the Netherlands). Total RNA from PPCCs was isolated by using TRI-Reagent (Sigma-Aldrich) following the manufacturer's instructions. Total RNA concentration was assessed by using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA). Total RNA (1 mg) from each sample was reverse-transcribed by using random hexamer primers and the complementary DNA (cDNA) First Strand Synthesis kit (Thermo Fisher Scientific).
The development, validation, and application of the quantitative polymerase chain reaction (qPCR) to measure the expression levels of different mouse transcripts have been previously reported (28) . The qPCR reactions were performed by using the qPCR Stratagene Mx3000p instrument (Agilent, Santa Clara, CA) with Brilliant III SYBR Green Master Mix (Agilent). Absolute gene expression levels were calculated by using a specific standard curve for each transcript analyzed. A no-reverse transcriptase sample was used as a negative control. To control for variations in the amount of RNA used and the efficiency of the reverse transcriptase reaction, the expression level of each transcript was adjusted by a normalization factor in each sample obtained from the expression levels of three housekeeping genes (b-actin, Hprt, and Cyclophilin A) using the Genorm program for the fresh PG tissues data or adjusted by Cyclophilin A for the PPCC data. The expression level of the housekeeping genes analyzed did not differ between experimental groups (data not shown). Specific sets of primers used in this study are shown in Supplemental Table 1 .
Western blot
PPCCs (450,000 cells per well) were washed with phosphatebuffered saline (PBS) and homogenized in radioimmunoprecipitation assay buffer [50 mM Tris-HCl (pH, 7.4), 0.1% sodium dodecyl sulfate, 0.1 mM EDTA, 0.150 mM NaCl, 1% sodium deoxycholate, 1% Tx-100, 0.1 mM chymostatin, leupeptin, aprotinin, and pepstatin, and 0.1 mM phenylmethylsulfonyl fluoride in distillated water]. Protein samples (from whole PGs or PPCCs) were mixed with Laemmli buffer (2-mercaptoethanol 0.1%, bromophenol blue 0.0005%, glycerol 10%, sodium dodecyl sulfate 2%, Tris-HCl 63 mM; pH, 6.8), final concentration (32)], boiled and separated on 10% acrylamide gels, and electrophoretically transferred to Hybond-ECL nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ) as previously described (27) . Blots were blocked in 5% nonfat dry milk (weightto-volume ratio) dissolved in Tris-buffered saline containing 0.1% Tween-20 (TBS-T) and incubated overnight (4°C) with the following primary antibodies against phospho-Ser473-Akt (catalog no. 9271), total-Akt (catalog no. 9272), phospho-Thr202/Tyr204-Erk (catalog no. 4370), and FABP4 (catalog no. 3544) (1:1000; Cell Signaling Technology, Beverly, MA); total Erk (SC154; 1:1000; Santa Cruz Biotechnology, Dallas, TX), adiponectin (NBP2-22450; 1:1000; Novus Biologicals, Littleton, CO), and resistin (ab119501; 1:500; Abcam, Cambridge, United Kingdom), in TBS-T and 5% nonfat dry milk. Then, blots were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (catalog no. 7074, Cell Signaling) for total Akt, phospho-Ser473-Akt, FABP4, total-Erk, phospho-Thr202/Tyr204-Erk and resistin (all 1:2000, except resistin at 1:1000) or with horse anti-mouse IgG horseradish peroxidase-linked antibody for adiponectin (1:2000; catalog no. 7076; Cell Signaling), in 5% dry milk, TBS-T for 1 hour, washed and exposed (5 minutes) to Clarity Western-ECL Blotting Substrate (1705060; BioRad). Membranes were scanned by using the ImageQuant Las 4000 system (GE Health Care Europe GmbH, Barcelona, Spain), and images were analyzed by using ImageJ software (National Institutes of Health, Bethesda, MD).
Prostate cell lines
Three human prostate-derived cell lines [one normal-like cell line (RWPE-1) and two prostate cancer (PCa)-derived cell lines [one androgen-independent (PC3) and one androgen-sensitive (LNCaP)] were obtained from ATCC and cultured and maintained under manufacturers' recommendations (reference: ATCC CRL-11609, ATCC CRL-1435 and ATCC CRL1740, respectively). All cell lines were validated by analysis of short tandem repeats (GenePrint ® 10 System; Promega, Barcelona, Spain) and checked for mycoplasma contamination by PCR, as recently reported (33) .
Measurements of proliferation
Proliferation of normal and tumoral prostate cell lines in response to leptin, adiponectin, and resistin was determined by AlamarBlue colorimetric assay (Thermo Fisher Scientific), as recently reported (33, 34) . Briefly, cells were seeded in 96-well plates (5000 cells per well; four wells per treatment; three to five independent experiments), 24-hour starved (serum-free medium) and proliferation rate measured at 24, 48, and 72 hours in response to treatments with human leptin (10 ng/mL; Phoenix Pharmaceuticals, Burlingame, CA), adiponectin (10 nM; SigmaAldrich), and resistin (10 nM; Phoenix Pharmaceuticals). The day of measurement, cells were incubated for 3 hours in 10% AlamarBlue/medium without FBS; then, AlamarBlue reduction was measured in FlexStation III (Molecular Devices, Madrid, Spain), exciting at 560 nm and reading at 590 nm. Immediately after the measurement, medium with AlamarBlue was replaced each day with fresh medium with 5% of FBS and with the different treatments.
Measurements of migration capacity
The ability of RWPE-1 cells to migrate in response to leptin (10 ng/mL), adiponectin (10 nM), and resistin (10 nM) was evaluated by wound-healing technique, as previously reported (34) . Briefly, cells were plated at subconfluence in 24-well plates (three wells per treatment). Confluent cells were serum-starved for 24 hours, and then a wound was made by using sterile pipette tips. At that moment, cells were rinsed in PBS and incubated for 14 hours in medium without FBS in the presence of different adipokines or medium alone (used as control). Migration was evaluated by the difference between the wound area before and 14 hours after the treatment using ImageJ software. At least three experiments were performed on independent days, in which three random photographs along the wound were acquired per well. Photographs were taken by using a Motic AE2000 camera (MoticEurope, Barcelona, Spain).
PSA secretion
Total PSA levels were measured by enzyme-linked immunosorbent assay in LNCaP cells following manufacturer's instructions (RAB0331, Sigma-Aldrich; specificity, detectability, and reproducibility of this assay can be found at the website of this company). Briefly, LNCaP cells were seeded in a 12-well plate at a density of 250,000 cells per well and incubated for 24 hours in medium with FBS. Cells were starved in medium without FBS for 2 hours and then incubated with leptin (10 ng/mL), adiponectin (10 nM), and resistin (10 nM) for 24 hours (three wells per treatment, four individual experiments). Medium was collected, centrifuged, and stored for PSA determination.
Statistical analysis
Samples from all groups were processed simultaneously and in parallel. Values are expressed as mean 6 standard error of the mean and compared with the corresponding controls (set at 100%). In all cases, a Kolmogorov-Smirnov test was applied to explore the normality of the values, and, subsequently, parametric or nonparametric t tests were implemented to analyze the statistical differences comparing each condition with the respective control. P , 0.05 was considered to indicate a statistically significant difference; when P values ranged between ,0.1 and .0.05, a trend for significance was indicated where appropriate. All statistical analyses were performed by using GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA).
Results
Presence and expression of adipokines and their receptors in prostate glands
The analysis of the expression of the different adipokines and receptors in whole PGs revealed that adiponectin and resistin are expressed at detectable but low levels [messenger RNA (mRNA) and protein], whereas leptin is not relevantly expressed based on method detection limit (i.e., ,10 copies/50 ng cDNA) [ Fig. 1(a) ]. In addition, adipokine receptors were also expressed in PGs; Adipor1 was the most abundantly expressed at the mRNA level, followed by Adipor2 and, to a lesser extent, Lepr [ Fig. 1(a) ]. We could not successfully validate the expression of Adipor at the protein level in PGs (as well as in adipose tissue and muscle, used as controls) by using a commercially available antibody (ab70362; Abcam). Importantly, the mRNA expression of these hormones and receptors was consistently maintained in PPCCs compared with whole PG tissues [ Fig. 1(b) ]. Specifically, Leptin and Lepr were not relevantly expressed (,10 copies/50 ng cDNA), whereas Adiponectin, Adipor1, and Adipor2 resembled the expression pattern exhibited in whole PGs. Remarkably, Resistin maintained similar expression levels in vitro compared with whole PGs [ Fig. 1(b) ]. These results strongly suggest that the cell preparation and culture conditions did not adversely affect the expression of transcripts important in the current study. Moreover, these results indicate that the culture system used allows for the maintenance of correct prostate cell function and suggests that information gained in this study could help improve understanding of the effects of these adipokines in mouse PGs.
To corroborate that PPCCs was not contaminated with adipose tissue and that, therefore, the presence and expression of adipokines and receptors were solely associated with PG cells, we analyzed the presence of fatty acid-binding protein 4 (an adipose tissue marker) and demonstrated that PPCCs did not present any detectable expression of fatty acid-binding protein 4 (i.e., free of adipose tissue cells [ Fig. 1(c) ]; visceral adipose tissues were used as positive control).
Regulation of adipokines and their receptors under different metabolic conditions (fasting and obesity)
As illustrated in Fig. 2(a) , under moderate-and longterm fasting conditions (12 hours and 24 hours), mice exhibited a significant reduction in body weight compared with fed-control mice [2.8 or 3.6 g after 12 or 24 hours (10% or 13% reduction), respectively]. Interestingly, Adiponectin and Resistin expression levels were not altered under these fasting conditions [ Fig.  2(b) ]. However, Adipor1 and Adipor2 expression levels were upregulated after 12 hours of fasting compared with the fed-control mice and then decreased to basal levels after 24 hours of fasting [ Fig. 2(c) ]. The expression levels of Lepr did not change during fasting conditions [ Fig. 2(c) ].
The validity of the obese model used in this study has been recently demonstrated and published elsewhere (27) . As illustrated in Fig. 3(a) , HF diet-fed mice at the moment of euthanasia exhibited a significantly higher body weight after 19 weeks of feeding (they were 17 g heavier than the LF diet-fed control mice). Interestingly, mRNA levels of Resistin Figure 2 . Effect of fasting on adipokine [adiponectin (Adipo) and resistin (Resis)] and receptor (leptin receptor and adiponectin receptors) expression profile in prostate. (a) Mice body weight. mRNA levels of (b) adiponectin (Adipo), resistin (Resis), and (c) Lepr, Adipor1, and Adipor2 in whole PG tissues of mice under fed (0 hours, n = 6) or fasting (12 hours, n = 6; 24 hours, n = 5) conditions. Data are represented as mean 6 standard error of the mean. Asterisks represent statistically significant differences (*P , 0.05; **P , 0.01). NF, normalization factor.
in the whole PG of obese mice were significantly reduced compared with LF diet controls, whereas only a nonsignificant trend (P , 0.1) was found for Adiponectin [ Fig. 3(b), top panel] . In contrast, mRNA levels of Adipor1, Adipor2, and Lepr were not altered under HF diet conditions [ Fig. 3(c) ]. Protein analysis corroborated the reduction of adiponectin, but not resistin, levels in PGs of HF diet-fed mice compared with LF diet-fed controls (P = 0.05 and P = 0.4, respectively ) [ Fig. 3(b) bottom panel]. Direct effect of leptin, adiponectin, and resistin on PPCCs We also evaluated the direct effect of leptin, adiponectin and resistin on their own expression as well as on the expression of their receptors (homologous and heterologous regulation) in mouse PGs using PPCCs [ Fig. 4(a) ]. Interestingly, our results revealed that leptin treatment promoted the reduction of resistin and the increase of Adipor1 mRNA levels; however, no significant effect was found on the expression of adiponectin, Adipor2, or Lepr. Our results also indicated that adiponectin reduced its own expression and presented a nonsignificant tendency to reduce resistin levels (P = 0.07) in PPCCs. Conversely, adiponectin treatment did not affect the expression of its own receptors (Adipor1 and Adipor2) or Lepr. Finally, resistin treatment reduced adiponectin and resistin expression and stimulated Adipor2 mRNA levels, but it had no effect on Adipor1 or Lepr expression [ Fig. 4(a) ].
We also determined whether the treatment with these adipokines had any effect on the expression of various proliferation markers in mouse PPCCs [ Fig. 4(b) ]. Remarkably, resistin [the predominant adipokine transcript expressed in PG tissues and PPCCs [ Fig. 1(a) and 1(b) ] significantly increased Ki67, p53, and c-Myc but not Men1 and Pcna mRNA levels in PPCCs [ Fig. 4(b) ]. Moreover, leptin treatment also significantly upregulated the expression of p53 in PPCCs but did not alter the expression of the other markers [ Fig. 4(b) ]. Finally, adiponectin treatment did not alter the expression of any of the proliferation markers analyzed [ Fig. 4(b) ].
Interestingly, leptin treatment clearly promoted ERK phosphorylation, whereas adiponectin or resistin did not elicit any significant changes on ERK activation (Fig. 5) . In contrast, AKT phosphorylation was not significantly altered in response to treatment with any of these three adipokines, although adiponectin treatment exhibited a slight tendency to increase phospho-Akt levels (P = 0.09) (Fig. 5) .
Direct effect of leptin, adiponectin, and resistin on normal and tumoral human cell lines
Normal and tumoral human prostate cell lines were used to assess the direct role of leptin, adiponectin, and resistin in key functional parameters, such as cell proliferation, migration, and PSA secretion (Fig. 6) . First, we observed that the three adipokines exerted a stimulatory effect on proliferation rate, which seemed to be time and cell line dependent. Particularly, leptin and adiponectin increased the proliferation (at 48 and 72 hours) and migration, whereas resistin stimulated only the migration capacity of normal (RWPE-1) cells [ Fig. 6(a) , left panel and 6(b)].
Additionally, we found that leptin and resistin, but not adiponectin, increased proliferation (72 hours or 48 or 72 hours, respectively) and PSA secretion of tumoral LNCaP cells [ Fig. 6(a) , middle panel, and 6(c)]. In contracts, only resistin stimulated proliferation rate (at 48 and 72 hours) in tumoral PC3 cells [ Fig. 6(a), right panel] .
Discussion
Adipokines play relevant roles in the modulation of several physiologic and pathologic conditions (1, 2, 35-37) . Indeed, these hormones [adiponectin (38, 39) , leptin (40) (41) (42) , and resistin (26, 43) ] affect PCa development and/or progression, and their receptors are expressed in PCa cells (44, 45) , wherein they are associated with PCa development (46, 47) . However, to date, there is still limited information about the expression, regulation, and function of these adipokine systems in normal prostate tissue under normal and in extreme metabolic conditions, such as obesity, a chronic endocrine/metabolic disease that has been associated with an increased incidence and aggressiveness of PCa (48) .
Earlier studies have demonstrated that leptin, adiponectin, and resistin and/or their receptors are widely expressed in many tissues, including the adipose tissue, brain, and muscle (11) (12) (13) (14) . In contrast with the wellknown expression of these adipokine and receptor systems in these tissues, to date only Lepr, Adipor1, and Adipor2 (but not the ligands) have been reported to be expressed by normal PGs from humans and mice (11) (12) (13) (14) . The present report a systematic analysis and comparison of the levels of expression of different components of the leptin, adiponectin, and resistin systems in normal PG tissues and in PPCCs.
Specifically, our data confirm previous results indicating that leptin and adiponectin receptors are expressed at the PG level and show that normal PGs and PPCCs also express these adipokines (at the mRNA and/ or protein level). Interestingly, we found that resistin was the most abundantly expressed adipokine, followed by adiponectin, whereas the expression of leptin was almost undetectable (i.e., close to the detection limit of qPCR). Moreover, we found that Adipor1 was the variant predominantly expressed in PG tissues and cell cultures (i.e., absolute mRNA copy number of Adipor1 . . Adipor2) and that Lepr was expressed at lower levels than Adipor1/2. This observation compares favorably with previous reports indicating that Adipor1 is the predominant adiponectin receptor expressed in endocrine-related tissue, such as the pituitary, and in muscle (49, 50) . Although the actual pathophysiologic and physiologic role of our results is still unknown, these data would support the notion that an autocrine and paracrine circuit involving the adipokines and receptors may operate directly at the PG level. This might have important pathophysiologic and physiologic implications.
In favor of this notion are our data indicating that treatment with different adipokines modulate the pathophysiologic function of normal prostate cells (PPCCs and RWPE-1; i.e., modulation of the expression of proliferation markers as well as the rate of proliferation and migration). Also supporting this idea are previous data indicating that leptin and adiponectin Asterisks represent statistically significant differences (*P , 0.05; **P , 0.01; ***P , 0.001).
receptors are also expressed in PCa cells and that different adipokine and receptor systems might have important roles in the development and progression of PCa (26, 51) , an aspect that is further discussed later.
A growing body of evidence supports the notion that adipokine levels change during conditions of metabolic dysregulation, such as fasting and/or obesity [i.e., leptin and resistin are elevated in obesity and decreased in fasting, whereas adiponectin is decreased in obesity and also decreased (or not altered) under fasting conditions (15-17, 21, 52)], wherein this modulation could be important for the homeostasis of different metabolic tissues (3, (15) (16) (17) . As expected, these changes resemble those occurring on the expression of adipokines in adipose tissue (which is the main source of circulating adipokines) (53); however, it is still to be defined whether the local expression of adipokines systems in other metabolic tissues behaves similarly. In this sense, our results revealed that fasting did not affect the expression of adiponectin and resistin in PGs, whereas expression of both adipokines was (or tended to be) reduced under obesity conditions (at the mRNA and/or protein level). The fact that obesity is associated with high circulating levels of resistin and leptin, together with the findings that these adipokines can directly downregulate adiponectin and/or resistin expression in PGs (results shown herein on in vitro PPCCs), leads us to suggest that an autocrine and endocrine negative feedback loop of these adipokine systems might operate in PGs under obesity conditions. This finding may be relevant from the pathophysiologic and physiologic point of view. In line with this, previous authors have suggested that obesity could promote the progression of PCa and that different adipokines may provide a molecular mechanism whereby obesity exerts its effects on prostate tumor biology (54, 55) . Moreover, it has been recently reported that obesity-related metabolic perturbations in some components of the leptin and adiponectin systems might be associated with more aggressive PCa (56) .
In line with the preceding, our results demonstrate that treatment with leptin and resistin (which are both increased in obesity) in normal prostate cells significantly increases the expression of different proliferation markers associated with PCa aggressiveness; the effect of resistin is more marked than the effect of leptin [i.e., resistin increased Ki67, c-Myc, and p53 expression, whereas leptin stimulated only p53 expression (57, 58) ]. These observations further support a direct association between alterations in the local and/or circulating levels of different adipokines in obesity and altered behavior (increased aggressiveness) of prostate cells. In fact, we found that leptin, adiponectin, and resistin increased aggressiveness (i.e., proliferation and/or migration) in normal RWPE-1 cells; this association could be of special clinical relevance in PCa, an endocrine-related cancer that is influenced by the level of these adipokines (26, (38) (39) (40) (41) (42) (43) . Indeed, our results revealed that leptin and resistin, but not adiponectin, increased proliferation and PSA secretion in LNCaP cells, whereas only resistin stimulated proliferation in PC3 cells. Moreover, we observed that PCa cells seemed to be more sensitive to resistin (which is the most abundantly expressed adipokine found in PGs) than to leptin, showing increased proliferation after 48 hours of incubation with resistin (but not leptin), as well as a higher stimulatory effect in proliferation at 72 hours and in PSA secretion in response to resistin compared with leptin. Therefore, these data confirm and expand previous results demonstrating a clear role of different adipokines on the aggressiveness of PCa cell function (26, 46, (59) (60) (61) and revealed a differential role of different adipokines on functional parameters associated with the pathophysiology of prostate cells, as leptin, adiponectin and resistin exerted different responses in terms of proliferation and PSA secretion depending on cell type analyzed [normal vs. tumoral (androgen-dependent vs. androgen-independent)] and on the duration of the treatment.
In terms of adipokine receptors at the PG level, we found that Adipor1 and Adipor2 were not altered under obese conditions but were upregulated after a short-term fasting period (12 hours), which is in line with previous data obtained from use of liver and skeletal muscle tissue (62) . Interestingly, these results could be of particular relevance as adiponectin improves insulin sensitivity (3), which might suggest that these changes occur during fasting to improve glucose uptake. Moreover, taking into account the hormonal changes associated with the different metabolic conditions (mouse models) used herein, and the in vitro evidence provided in this study, we could speculate that the reduction of circulating insulin (62) , leptin, and/or resistin (15-17) occurred during fasting and could lead to a higher sensitivity of the PG by the upregulation of Adipor1/2. In contrast, the expression of Adipor1/2 was not altered in obesity, as it is observed in other tissues [i.e. liver, muscle, or fat (11) (12) (13) (14) ], suggesting that these changes are observed only in fasting. Moreover, the expression of Lepr was not significantly altered in fasting or in obese conditions, which is consistent with previous studies implemented in other rat tissues (63) .
Finally, our results also demonstrate that, at the PG level, some adipokines systems can exert other functions in addition to those previously mentioned (i.e., modulation of proliferation markers in normal PPCCs, as well as regulation of proliferation, migration, and PSA secretion in normal and tumoral prostate cells), and that these systems display an ample landscape of homologous and heterologous regulations. Thus, treatment with these adipokines activated relevant signaling pathways and modulated the expression of other adipokines and receptors. Particularly, leptin increased p-ERK1/2 levels, which was accompanied by a reduction of resistin and by an increase in Adipor1 expression. Moreover, resistin reduced its own expression and adiponectin and Adipor2 expression. In contrast, adiponectin did not alter any of the functional parameters analyzed in this setting. Accordingly, all the direct actions of different adipokines on PG cells reported herein, together with the local expression of adipokines and/or receptors in normal (present study) and tumoral (previous studies) (26, 51) PGs, further support the notion that an autocrine and paracrine effect (i.e., a feedback regulatory loop) of some adipokine systems might operate in PG cells. This could have important clinical relevance and be especially important under extreme metabolic conditions (i.e., obesity and PCa).
Conclusions
When viewed as a whole, our data show that various adipokine and receptor systems are differentially expressed in normal PG cells and that their expression is under a complex, ligand-and receptor-selective regulation under extreme metabolic conditions (i.e., fasting and obesity). Moreover, the present results demonstrate that leptin, adiponectin, and resistin mediate common and distinct direct actions in normal and tumoral PG cells (i.e., homologous and heterologous regulation of adipokine and receptor synthesis; modulation of proliferation markers; activation of ERK signaling; and regulation of cell proliferation, migration, and PSA secretion), which suggests a relevant role of these adipokine systems in the regulation of PG pathophysiology. 
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